Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 6/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | THRB | P10828 | 3/20 | 0.42 |
| ▸ | HMGCR | P04035 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.34 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11068064 | 0.86 | GAA (0.41) | GAAKMT2AHMGCRTSHRMEN1 | |
| SCHEMBL2671206 | 0.82 | THRB (0.42) | GAAKMT2ATHRBHMGCRTSHR | |
| SCHEMBL466169 | 0.80 | SMN1; SMN2 (0.47) | GAAKMT2AHMGCRTSHRMEN1 | |
| SCHEMBL10622475 | 0.80 | CYP3A4 (0.45) | GAAHMGCRTSHRALDH1A1CYP1A2 | |
| SCHEMBL4157320 | 0.75 | GAA (0.46) | GAAKMT2AHMGCRTSHRMEN1 | |
| SCHEMBL6449224 | 0.74 | HSPA5 (0.49) | GAAKMT2ATHRBTSHRMEN1 | |
| SCHEMBL6394388 | 0.74 | TSHR (0.52) | GAAKMT2AHMGCRTSHRMEN1 | |
| SCHEMBL5412953 | 0.73 | GAA (0.56) | GAAKMT2ATHRBTSHRMEN1 | |
| Acrylic Acid SCHEMBL6449228 | 0.73 | HSPA5 (0.57) | GAAKMT2ATHRBTSHRMEN1 | |
| SCHEMBL2265057 | 0.73 | GAA (0.55) | GAAKMT2AHMGCRTSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6861552-B2 | Adamantyl ester monomer composition | TOKUYAMA CORPORATION (JP) | 2005-03-01 | — | — | US | disclosed |
| US-20040015008-A1 | Adamantyl ester monomer composition | TOKUYAMA CORPORATION (JP) | 2004-01-22 | — | — | US | disclosed |
| EP-1306363-A1 | ADAMANTYL ESTER MONOMER COMPOSITION | TOKUYAMA CORPORATION (JP) | 2003-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040015008-A1 | Adamantyl ester monomer composition | PRMT1, HSD11B1, HSD3B1 | GAA 4694/4885KMT2A 2307/4885THRB 4613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.